B2Gold delivered strong Q2'25 operational and financial results, with all mines outperforming their budget and the company hitting its free cash flow inflection point. The company continues to lay the foundation for an improved production profile at Otjikoto (Springbok), a potential 5th mine in Gramalote, and a possible expansion at Goose (4k-->6k TPD). Given BTG's strong long-term track record, room for multiple expansions with a new Tier-1 jurisdiction asset in production, and deep discount to peers, sharp pullbacks should offer buying opportunities.
Golden Entertainment's deleveraging and strong cash flow support robust buybacks and dividends, offering at least 7% annual shareholder returns even in conservative scenarios. Despite a downgrade from Truist Securities citing Strat weakness and muted M&A prospects, I maintain my $32 price target and 'Buy' rating, seeing the downgrade as an opportunity. Q2 headwinds are real but manageable; room occupancy and slot performance show resilience, and FCF coverage for dividends and buybacks remains solid under all scenarios.
Nvidia Corporation delivered strong Q1 revenue growth and outperformed expectations, despite a significant gross margin hit from China export restrictions. Data Center and Gaming segments remain robust growth engines, with AI demand and new product launches driving results. Valuation is elevated but justified by Nvidia's market leadership, high earnings growth, and strong free cash flow generation.
9 Aug 2024 Date | | - Cons. EPS | - EPS |
15 May 2024 Date | | - Cons. EPS | - EPS |
10 Apr 2024 Date | | - Cons. EPS | - EPS |
31 Dec 2016 Date | | - Cons. EPS | 0.44 EPS |
30 Sep 2016 Date | | - Cons. EPS | - EPS |
9 Aug 2024 Date | | - Cons. EPS | - EPS |
15 May 2024 Date | | - Cons. EPS | - EPS |
10 Apr 2024 Date | | - Cons. EPS | - EPS |
31 Dec 2016 Date | | - Cons. EPS | 0.44 EPS |
30 Sep 2016 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Adam L. Hershey CEO | OTC PINK Exchange | US36930V1008 ISIN |
United States Country | 91 Employees | - Last Dividend | - Last Split | - IPO Date |
Trees Corporation, initially known as General Cannabis Corp., is a prominent entity within the regulated cannabis industry in the United States, having undergone a name change in June 2022. This transition reflects its focus and growth within the sector. Founded in 2013 and based in Lakewood, Colorado, Trees Corporation has carved a niche for itself by offering a range of products and services through its Retail and Cultivation segments. The company's operations are strategically spread across notable locations, including a licensed 17,000 square foot light deprivation greenhouse cultivation facility and a retail dispensary store in Englewood, Colorado. Moreover, it extends its retail reach to Portland, Oregon, showcasing its intention to cater to a broad spectrum of the cannabis market. Trees Corporation’s evolution from General Cannabis Corp to its current state is a testament to its dedication and adaptability within the dynamic and evolving cannabis industry.
This standout establishment offers an extensive range of regulated cannabis products catering to both medical and recreational users. With a focus on quality and safety, the Englewood store serves as a hallmark of Trees Corporation’s commitment to providing premium cannabis products within a regulated environment.
Expanding its footprint, Trees Corporation operates retail stores in Portland, Oregon, aiming to meet the growing demand in the region. These stores replicate the company's dedication to excellence, offering a diverse selection of cannabis products to satisfy a wide array of customer preferences and needs.
In the cultivation segment, Trees Corporation boasts a state-of-the-art 17,000 square foot greenhouse. This facility utilizes light deprivation techniques to optimize plant growth conditions, ensuring the production of high-quality cannabis. This cultivation method highlights Trees Corporation’s investment in sustainable practices and technological advancements to meet the ever-increasing quality standards of the cannabis industry.